Global Agricultural Adjuvants Report 2017: Market, Analysis & Forecasts 2016-2021
Nov 13, 2017 14:04 pm UTC| Business
Dublin, Nov. 13, 2017 -- The "Global Agricultural Adjuvants Market, Analysis Forecast (2016-2021)" report has been added to Research and Markets' offering. The growing demand of agrochemicals, increasing...
CAST Research on the State of Software Security Reveals Riskiest Applications
Nov 13, 2017 14:01 pm UTC| Business
NEW YORK, Nov. 13, 2017 -- CAST, the leader in software intelligence, today announced the findings from its global benchmarking report on the state of software security. The CRASH Report on Application Security reveals...
Akers Biosciences Announces Conference Call to Discuss Q3 2017 Earnings
Nov 13, 2017 14:01 pm UTC| Business
THOROFARE, N.J., Nov. 13, 2017 -- Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (“Akers Bio” or the "Company"), a developer of rapid health information technologies, will hold a conference call on Wednesday,...
Dow Jones launches NewsPicks to revolutionize quality content curation
Nov 13, 2017 14:01 pm UTC| Business
Joint technology venture with Japan’s Uzabase provides users with curated articles chosen by trusted influencers and journalists from around the globeArianna Huffington and Richard Branson among high profile news curators ...
Nov 13, 2017 14:01 pm UTC| Business
TURBO, ANTIOQUIA, Colombia, Nov. 13, 2017 -- Inca Worldwide (OTC Pink:QEDN), working through Green Mine Solutions SAS (GMS), has entered into an alliance with the Colombian government in regard to the government’s plan...
Micron Advances Persistent Memory with 32GB NVDIMM
Nov 13, 2017 14:01 pm UTC| Business
DENVER, Nov. 13, 2017 -- At the SC17 show, Micron Technology, Inc., (Nasdaq:MU) today announced a new 32GB NVDIMM-N offering twice the capacity of existing NVDIMMs, providing system designers and original equipment...
Cytori Announces New U.S. Investigator Trial for Hip Osteonecrosis
Nov 13, 2017 14:01 pm UTC| Business
SAN DIEGO, Nov. 13, 2017 -- Cytori Therapeutics, Inc. (Nasdaq:CYTX) (“Cytori” or “the Company”) today announced a new investigator initiated U.S. clinical trial for hip osteonecrosis. Details of the trial can be...
FDA Approval of Opdivo Injection Sparks Hope for Cancer Patients with Revolutionary Treatment Update